AR246870A1 - Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres. - Google Patents

Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres.

Info

Publication number
AR246870A1
AR246870A1 AR90317250A AR31725090A AR246870A1 AR 246870 A1 AR246870 A1 AR 246870A1 AR 90317250 A AR90317250 A AR 90317250A AR 31725090 A AR31725090 A AR 31725090A AR 246870 A1 AR246870 A1 AR 246870A1
Authority
AR
Argentina
Prior art keywords
hydrogen
carbon atoms
contraceptives
males
group
Prior art date
Application number
AR90317250A
Other languages
English (en)
Original Assignee
Cohen Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cohen Michael filed Critical Cohen Michael
Application granted granted Critical
Publication of AR246870A1 publication Critical patent/AR246870A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION PARA EFECTUAR ANTICONCEPCION EN HOMBRES, QUE COMPRENDE MEZCLAR UNA CANTIDAD ANTICONCEPTIVAMENTE EFECTIVA DE MELATONINA O UN ANALOGO DE MELATONINA QUE TIENE LA FORMULA GENERAL (I), DONDE R1, R3 Y R4, INDIVIDUALMENTE, SON HIDROGENO O UN GRUPO ALQUILO QUE TIENE DE 1 A 4 ATOMOS DE CARBONO, R2 SE SELECCIONA DE HIDROGENO, HIDROXI O UN GRUPO ALCOXI QUE TIENE DE 1 A 4 ATOMOS DE CARBONO, Y A SE SELECCIONA DEL GRUPO QUE CONSISTE DE -OH O -HN-CO-R5 EN DONDE R5 ES YA SEA HIDROGENO O UN GRUPO ALQUILO QUE TIENE DE 1 A 4 ATOMOS DE CARBONO, A CONDICION DE QUE SI A ES -HN-CO-R5, Y R1 Y R5 SON AMBOS METILO Y R2 ES HIDROGENO, NI R3 Y R4 SON HIDROGENO, CON UNA CANTIDAD EFECTIVA PARA INDUCIR AZOOSPERMIA DE UNA O MAS HORMONAS SELECCIONADAS DE UN ANDROGENO, UN PROGESTOGENO Y UN ESTROGENO, Y MEZCLAR LA MEZCLA ASI OBTENIDA CON UN ADYUVANTE SOLIDO O LIQUIDO.
AR90317250A 1989-06-27 1990-06-27 Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres. AR246870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37179489A 1989-06-27 1989-06-27

Publications (1)

Publication Number Publication Date
AR246870A1 true AR246870A1 (es) 1994-10-31

Family

ID=23465430

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90317250A AR246870A1 (es) 1989-06-27 1990-06-27 Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres.

Country Status (17)

Country Link
EP (1) EP0479867B1 (es)
JP (1) JPH07507037A (es)
CN (1) CN1048327A (es)
AR (1) AR246870A1 (es)
AT (1) ATE137970T1 (es)
AU (1) AU639467B2 (es)
CA (1) CA2059138A1 (es)
DD (2) DD297327A5 (es)
DE (1) DE69027028T2 (es)
EG (1) EG19390A (es)
GR (1) GR1002142B (es)
IL (1) IL94869A (es)
IN (1) IN171596B (es)
NZ (1) NZ234210A (es)
PT (1) PT94493A (es)
WO (1) WO1991000095A1 (es)
ZA (1) ZA905020B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141051T1 (de) 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US5401669A (en) * 1993-05-13 1995-03-28 Memc Electronic Materials, Spa Process for the preparation of silicon wafers having controlled distribution of oxygen precipitate nucleation centers
AU5984196A (en) * 1995-06-07 1996-12-30 Merck & Co., Inc. Treatment and prevention of prostatic disease
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
GB9813278D0 (en) * 1998-06-20 1998-08-19 Medical Res Council Male contraceptive
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
US6119870A (en) * 1998-09-09 2000-09-19 Aec Oil Sands, L.P. Cycloseparator for removal of coarse solids from conditioned oil sand slurries
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Also Published As

Publication number Publication date
PT94493A (pt) 1991-02-08
CN1048327A (zh) 1991-01-09
IL94869A (en) 1994-10-07
DD299619A5 (de) 1992-04-30
DD297327A5 (de) 1992-01-09
DE69027028T2 (de) 1996-09-26
GR900100489A (el) 1991-11-15
EG19390A (en) 1995-01-31
ZA905020B (en) 1991-04-24
IN171596B (es) 1992-11-21
EP0479867B1 (en) 1996-05-15
CA2059138A1 (en) 1990-12-28
GR1002142B (en) 1996-02-15
DE69027028D1 (de) 1996-06-20
EP0479867A1 (en) 1992-04-15
AU5968390A (en) 1991-01-17
JPH07507037A (ja) 1995-08-03
WO1991000095A1 (en) 1991-01-10
ATE137970T1 (de) 1996-06-15
AU639467B2 (en) 1993-07-29
NZ234210A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
MX166092B (es) Composicion de cemento con resistencia mejorada y procedimiento para aumentar la resistencia de mezclas de cementos hidraulicos
ES474047A1 (es) Procedimiento para preparar un cebo para moscas sinantropas
ES2062728T3 (es) Composicion cosmetica anhidra en forma de espuma aerosol.
BR9807484A (pt) Concentrados de agente tensoativo de baixa espumação para promover crescimento de plantas
KR890006755A (ko) 수-기제 실리콘-유기 중합체 조성물 및 이의 제조방법
AR246870A1 (es) Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres.
ES493526A0 (es) Procedimiento para la obtencion de masas de moldeo de orga- nopolisiloxano
AU527592B2 (en) 3,20-dioxo-4,9-diene-21-hydroxyl steroid derivatives
ES369571A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas..
DE69902684T2 (de) Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11
ES529335A0 (es) Procedimiento para la obtencion de esteres sustituidos de tiazolidinilo de acidos minerales
PT87117A (pt) Verfahren zur herstellung von 17alpha-ethinyl-17beta-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
WO2001053321A3 (en) Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers
ES383723A1 (es) Procedimiento para la obtencion de 17 alfa-alquil-11-beta- 13-beta-dialquilgona-1, 3, 5 (10)-trieno-3,17 beta-diol-3- cicloalquil eteres.
DE3379947D1 (en) Nitromethylating reagent, its utilization in the preparation of nitromethylated compounds and some of their derivatives and the compounds obtained
GB1117685A (en) Siloxane greases
DK147684C (da) Analogifremgangsmaade til fremstilling af 16alfa-ethyl-4,9,11-oestratrien-3-oner
GB1029046A (en) Steroid compounds
KR900004643A (ko) 모르타르 또는 콘크리트 구조물의 품질향상방법 및 혼화제
EP0139907A3 (en) Estrane derivatives
JPS56129013A (en) Defoaming agent composition
ES2175513T3 (es) Uso de un aditivo inhibidor de la cristalizacion para glucosidos tensioactivos no ionicos.
ES372444A1 (es) Procedimiento para preparar un agente de hidrofobacion mi- crobiocida.
ES303114A1 (es) Procedimiento para preparar gonadienonas
KR880005201A (ko) 반도체 봉지용 에폭시수지 조성물